Sonia Maciá

LAVA Therapeutics

Sonia Maciá is an ESMO-certified medical oncologist. She obtained a master’s degree in pharmacoeconomics from Universitat Pompeu Fabra Barcelona and a Ph.D. in lung cancer from the University Miguel Hernández. She has an Executive MBA from EAE/University of Barcelona. Dr. Maciá worked as a practicing medical oncologist for nine years and then decided to devote her career to clinical research. After working for different CROs, she joined Highlight Therapeutics to work on clinical development for intratumoral immunotherapies. Currently, Dr. Maciá is Executive Medical Director at LAVA Therapeutics, working on early development with several immunotherapies for solid and hematologic malignancies. Dr. Maciá has submitted more than 40 abstracts to international conferences, published more than 30 papers in peer-reviewed journals, and authored six book chapters.

Sonia Maciá

2books edited

2chapters authored

Latest work with IntechOpen by Sonia Maciá

Melanoma is an aggressive type of cancer for which treatment has dramatically evolved during the last 15 years, improving response and survival figures. This book, written by a diverse panel of experts, presents a description of the most relevant aspects of the epidemiology, diagnosis, local treatment, prognostic biomarkers and treatment for advanced disease, including the most recent research on novel molecules that are either approved or are undergoing clinical development. It includes insights on such challenging topics as when immunotherapy should be started in BRAF mutant patients, or which is the most appropriate treatment algorithm in those cases, as well as how to handle difficult and poor-prognosis melanoma cases, such as patients with brain metastases or patients with the uveal disease.

Go to the book